Emvododstat clinical trials
Also written PTC299.
How each study uses emvododstat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2018 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses emvododstat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)TerminatedPhase 2/3PTC TherapeuticsNCT04439071Written as PTC299
- Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute LeukemiasTerminatedPhase 1PTC TherapeuticsNCT03761069Written as PTC299
- PTC299 for Treatment of Advanced CancerTerminatedPhase 1PTC TherapeuticsNCT00704821Written as PTC299
- PTC299 for Treatment of Neurofibromatosis Type 2TerminatedPhase 2PTC TherapeuticsNCT00911248Written as PTC299
- PTC299 and Hormonal Agent for Treatment of Metastatic Breast CancerCompletedPhase 1PTC TherapeuticsNCT00508586Written as PTC299
Codes
What other systems call emvododstat · ClinicalTrials.gg INT001476
- MeSH (NLM) C000711752emvododstatOne source NLM
- UNII (FDA) 053QD2I96AEMVODODSTATConfirmed FDA, NLM
- NCI Thesaurus C91100EmvododstatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000711752 | emvododstat | One source NLM |
| UNII (FDA) | 053QD2I96A | EMVODODSTAT | Confirmed FDA, NLM |
| NCI Thesaurus | C91100 | Emvododstat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.